Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Hospitalizations Among New Users of Combination Maintenance Inhalers.
Feldman WB, Avorn J, Kesselheim AS, Gagne JJ.
JAMA Intern Med. 2023 07 01. 183(7):685-695. PMID: 37213116
Adjunct Faculty
Joshua J Gagne
Links
Bibliography
Prospective validation of a dynamic prognostic model for identifying COVID-19 patients at high risk of rapid deterioration.
Lin KJ, D'Andrea E, Desai RJ, Gagne JJ, Liu J, Wang SV.
Pharmacoepidemiol Drug Saf. 2023 05. 32(5):545-557. PMID: 36464785
Letter to the Editor Regarding Long-Term Benefit-Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis.
Pettitt D, Plotnick M, Gagne J.
Dermatol Ther (Heidelb). 2022 Dec. 12(12):2863-2866. PMID: 36271223
Association between initiation of fluoroquinolones and hospital admission or emergency department visit for suicidality: population based cohort study.
Wang J, Gagne JJ, Kattinakere-Sreedhara S, Fischer MA, Bykov K.
BMJ. 2022 10 04. 379:e069931. PMID: 36195324
Partition testing for real-world evidence studies.
Cafri G, Wood J, Gagne J.
Pharmacoepidemiol Drug Saf. 2022 Dec. 31(12):1280-1286. PMID: 36089808
Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study.
Suruki RY, Desai RJ, Davis KJ, Berlin JA, Gagne JJ.
Rheumatology (Oxford). 2022 08 03. 61(8):e236-e237. PMID: 35333307
Comparative Risk of Opioid Overdose With Concomitant Use of Prescription Opioids and Skeletal Muscle Relaxants.
Khan NF, Bykov K, Barnett ML, Glynn RJ, Vine SM, Gagne JJ.
Neurology. 2022 09 27. 99(13):e1432-e1442. PMID: 35835561
Type of Oral Anticoagulant and Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for VTE-Reply.
Bykov K, Gagne JJ.
JAMA. 2022 07 05. 328(1):79. PMID: 35788796
Association of Type of Oral Anticoagulant Dispensed With Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for Venous Thromboembolism.
Pawar A, Gagne JJ, Gopalakrishnan C, Iyer G, Tesfaye H, Brill G, Chin K, Bykov K.
JAMA. 2022 03 15. 327(11):1051-1060. PMID: 35289881
Transparency of high-dimensional propensity score analyses: Guidance for diagnostics and reporting.
Tazare J, Wyss R, Franklin JM, Smeeth L, Evans SJW, Wang SV, Schneeweiss S, Douglas IJ, Gagne JJ, Williamson EJ.
Pharmacoepidemiol Drug Saf. 2022 04. 31(4):411-423. PMID: 35092316